Cardiovascular Business

The cardiovascular business channel offers news and new technologies to aid the business management of the cardiovascular service line.

News | SCAI

May 10, 2022 — After two years of virtual meetings, the Society for Cardiovascular Angiography & Interventions (SCAI) ...

Home May 10, 2022
Home
 Primary tabs View(active tab) Edit Delete Revisions Entityqueue Devel Open configuration options Open configuration options Videos | Venous Therapies | June 27, 2017 VIDEO: How the Ekos Thrombolytic Technology Works to Dissolve Clots Open Related Chest Pain Imaging Content: configuration options Venous Thrombolytic System Demonstration  Play  Mute Remaining Time -3:23  Picture-in-Picture  Fullscreen This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat dee
Feature | Cardiovascular Business

Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...

Home May 09, 2022
Home
Image of late comedian Gilbert Gottfried from Wikipedia
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of April ...

Home May 02, 2022
Home
News | Cardiovascular Business

April 29, 2022 – Providing excellent care inside and outside of the traditional hospital is the new normal for patients ...

Home April 29, 2022
Home
HIMSS22 showed that the industry is back on track, with leading organizations showcasing solutions for staff shortages and related burnout, cybersecurity, digital transformation, image convergence and efficiency
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

You could feel the energy and excitement at the 2022 HIMSS Global Health Conference & Exhibition (HIMSS22) held this ...

Home April 29, 2022
Home
Blog | Cardiovascular Business

During a Philips international media roundtable at HIMSS22, Mandi Bishop, vice president analyst at Gartner, a ...

Home April 29, 2022
Home
News | Ventricular Assist Devices (VAD)

April 28, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that ...

Home April 28, 2022
Home
News | Heart Failure

April 25, 2022 — Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer ...

Home April 25, 2022
Home
News | ASE

April 21, 2022 – The American Society of Echocardiography (ASE) is pleased to announce that its membership has elected ...

Home April 21, 2022
Home
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

Home March 31, 2022
Home
Subscribe Now